# Octapharma Plasma, Inc. – FDA Inspection, Dec 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/6b0697a4-0c87-4f89-a0b9-84d51ae64f8c
Source feed: FDA_Inspections

> FDA inspection 1036565 of Octapharma Plasma, Inc., December 29, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 640. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1036565
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2017-12-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1172652 - 2022-06-16
- FDA Inspection 865572 - 2014-02-06
- FDA Inspection 760574 - 2011-12-23
- FDA Inspection 597584 - 2009-07-10

## Related Officers

- [Erma Zaimova](https://www.keypedia.com/people/erma-zaimova/87da23ad-48bb-4096-9d8a-e8511c6b5c98)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/6e8b1ca0-cc63-4e8f-9a4c-a4bb56aedec8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d